148 related articles for article (PubMed ID: 22926348)
1. Metabolic syndrome and psychotropic medications.
Filaković P; Petek Erić A; Radanović-Grgurić L
Med Glas (Zenica); 2012 Aug; 9(2):180-8. PubMed ID: 22926348
[TBL] [Abstract][Full Text] [Related]
2. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN
Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic drug considerations in depressed patients with metabolic disturbances.
Vieweg WV; Levy JR; Fredrickson SK; Chipkin SR; Beatty-Brooks M; Fernandez A; Hasnain M; Pandurangi AK
Am J Med; 2008 Aug; 121(8):647-55. PubMed ID: 18691474
[TBL] [Abstract][Full Text] [Related]
4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics.
Centorrino F; Masters GA; Talamo A; Baldessarini RJ; Öngür D
Hum Psychopharmacol; 2012 Sep; 27(5):521-6. PubMed ID: 22996619
[TBL] [Abstract][Full Text] [Related]
6. Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.
Vandenberghe F; Gholam-Rezaee M; Saigí-Morgui N; Delacrétaz A; Choong E; Solida-Tozzi A; Kolly S; Thonney J; Gallo SF; Hedjal A; Ambresin AE; von Gunten A; Conus P; Eap CB
J Clin Psychiatry; 2015 Nov; 76(11):e1417-23. PubMed ID: 26646038
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and mental illness.
Newcomer JW
Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome & psychiatric disorders.
Singh SM; Mattoo SK
Indian J Med Res; 2008 Sep; 128(3):237-45. PubMed ID: 19052333
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome in severe mental disorders.
Ohaeri JU; Akanji AO
Metab Syndr Relat Disord; 2011 Apr; 9(2):91-8. PubMed ID: 20964513
[TBL] [Abstract][Full Text] [Related]
10. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
11. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
Yogaratnam J; Biswas N; Vadivel R; Jacob R
East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
[TBL] [Abstract][Full Text] [Related]
12. Mental illness and metabolic syndrome--a literature review.
Łopuszańska UJ; Skorzyńska-Dziduszko K; Lupa-Zatwarnicka K; Makara-Studzińska M
Ann Agric Environ Med; 2014; 21(4):815-21. PubMed ID: 25528926
[TBL] [Abstract][Full Text] [Related]
13. Use of psychotropic drugs and associated dental diseases.
Fratto G; Manzon L
Int J Psychiatry Med; 2014; 48(3):185-97. PubMed ID: 25492713
[TBL] [Abstract][Full Text] [Related]
14. 'Why getting fat, Doc?' Weight gain and psychotropic medications.
Malhi GS; Mitchell PB; Caterson I
Aust N Z J Psychiatry; 2001 Jun; 35(3):315-21. PubMed ID: 11437804
[TBL] [Abstract][Full Text] [Related]
15. Association between psychoactive medications and delirium in hospitalized patients: a critical review.
Gaudreau JD; Gagnon P; Roy MA; Harel F; Tremblay A
Psychosomatics; 2005; 46(4):302-16. PubMed ID: 16000673
[TBL] [Abstract][Full Text] [Related]
16. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
18. Avoiding psychotropic drug interactions in the cardiovascular patient.
DeVane CL; Markowitz JS
Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
[TBL] [Abstract][Full Text] [Related]
19. Psychoactive drug interactions with pharmacotherapy for diabetes.
DeVane CL; Markowitz JS
Psychopharmacol Bull; 2002; 36(2):40-52. PubMed ID: 12397839
[TBL] [Abstract][Full Text] [Related]
20. Weight gain associated with taking psychotropic medication: an integrative review.
McCloughen A; Foster K
Int J Ment Health Nurs; 2011 Jun; 20(3):202-22. PubMed ID: 21492360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
